Does FIBRINOGEN HUMAN Cause Poor venous access? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Poor venous access have been filed in association with FIBRINOGEN HUMAN (TachoSil). This represents 2.5% of all adverse event reports for FIBRINOGEN HUMAN.
10
Reports of Poor venous access with FIBRINOGEN HUMAN
2.5%
of all FIBRINOGEN HUMAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Poor venous access From FIBRINOGEN HUMAN?
Of the 10 reports.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FIBRINOGEN HUMAN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does FIBRINOGEN HUMAN Cause?
Foetal exposure during pregnancy (40)
No adverse event (38)
Off label use (38)
Drug ineffective (34)
Hypotension (31)
Foetal anaemia (27)
Foetal growth restriction (27)
Haemorrhage in pregnancy (26)
Anaphylactic shock (25)
Maternal exposure during pregnancy (25)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which FIBRINOGEN HUMAN Alternatives Have Lower Poor venous access Risk?
FIBRINOGEN HUMAN vs FIBRINOGEN HUMAN\HUMAN THROMBIN
FIBRINOGEN HUMAN vs FIBRINOGEN HUMAN\THROMBIN HUMAN
FIBRINOGEN HUMAN vs FIDAXOMICIN
FIBRINOGEN HUMAN vs FILGOTINIB
FIBRINOGEN HUMAN vs FILGRASTIM